Short Interest Reporting: A Reversal for AMERICANN INCORPORATED (OTCMKTS:ACAN) Is Not Near. The Stock Has Rise in Shorts

November 23, 2016 - By Adrian Mccoy   ·   0 Comments

Short Interest Reporting: A Reversal for AMERICANN INCORPORATED (OTCMKTS:ACAN) Is Not Near. The Stock Has Rise in Shorts

The stock of AMERICANN INCORPORATED (OTCMKTS:ACAN) registered an increase of 75% in short interest. ACAN’s total short interest was 9,100 shares in November as published by FINRA. Its up 75% from 5,200 shares, reported previously. With 175,700 shares average volume, it will take short sellers 0 days to cover their ACAN’s short positions. The stock closed at $1.09 during the last session. It is down 65.15% since April 21, 2016 and is uptrending. It has outperformed by 59.82% the S&P500.

AmeriCann, Inc. develops, owns and supports medical cannabis cultivation and processing facilities. The company has a market cap of $18.13 million. The Firm has a multi-market portfolio of over 1,000,000 square feet of cannabis production infrastructure in various stages of development, which consists of approximately 125,000 square feet of approved cultivation and processing infrastructure on over five acres located at 5280 Monaco St. in Denver, and site approval for approximately 977,000 square feet of cultivation, processing and administration infrastructure at the Massachusetts Medical Cannabis Center . It currently has negative earnings. To support local businesses that seek to serve cannabis patients in their communities, the Company initiated the AmeriCann Preferred Partner Program.

More news for Americann Inc (OTCMKTS:ACAN) were recently published by: Prnewswire.com, which released: “AmeriCann Partners with Medical Marijuana Applicants in Illinois in $9 Million …” on October 20, 2014. 9News.com‘s article titled: “Colorado medical-pot company to buy Massachusetts site from Samuel Adams beer …” and published on May 11, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>